Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5867 posts found.

cambridge_biomedical_campus

Delivering the life sciences agenda: Easy as ABC

January 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical

Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abcam, Alzheimer's, Dr Reddy's, GSK, J&J, JJ, Reckitt Benckiser, Remicade, Sanofi, influenza, opioid crisis, opioids, top ten, valproate

As we come to the end of January, it’s Friday again – time for another rundown of the top ten …
News
alex_azar_wwsg_photo_cropped

Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate

January 25, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma

Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …
News
jj_sign_on_wall

J&J withdraws controversial vaginal mesh from Australian market

January 23, 2018 Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, pharma, vaginal mesh

Johnson & Johnson has withdrawn its controversial vaginal mesh product from the Australian market after missing a deadline requiring all …
News
shutterstock_274590824

GSK wins case against Reckitt Benckiser over misleading ad campaign

January 23, 2018 Manufacturing and Production, Sales and Marketing GSK, GlaxoSmithKline, Nurofen, Panadol, Reckitt Benckiser, ibuprofen, paracetamol, pharma

GlaxoSmithKline is celebrating as it emerges that the UK pharma giant triumphed in its legal battle against Reckitt Benckiser after …
News
teva_copy

More woes for Teva as two late-stage asthma studies bomb

January 23, 2018 Manufacturing and Production, Research and Development Teva, asthma, pharma

In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have …
News

Bristol-Myers Squibb’s Yervoy scores EU approval in paediatric melanoma

January 23, 2018 Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, EU, Yervoy, pharma

Bristol-Myers Squibb has revealed that its immunotherapy Yervoy (ipilimumab) has received an expanded indication from the European Commission, approving the …
News
celgene_exteriors-3

Celgene confirms rumours, with $9bn deal for Juno

January 22, 2018 Manufacturing and Production, Sales and Marketing CAR-T, Celgene, biotech, drugs, juno therapeutics, pharma, pharmaceutical

It seems like 2018 may well be the year for M&A that everyone had expected, as two major deals on …
News
nicolas_raymond

The measurement underpinning government goals for UK life sciences

January 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Industrial Strategy, brexit, john bell, life sciences, pharma

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Boehringer, CAR T, CAR-T, Celgene, Kymriah, Merck KGaA, Novartis, Philippines, Sanofi, gilotrif, juno therapeutics, nestle, top ten

It’s Friday, so it’s time to bring you another run-down of the top ten most popular articles with Pharmafile.com’s readers …
News
sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

January 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …
Feature
filippo_6_for_internal_use_online

GSK Consumer Healthcare announces new Asia Pacific Regional Head

January 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline

GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …
Appointment
surinder

Hikma bring in new CSO

January 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hikma, biotech, drugs, pharma, pharmaceutical

Hikma Pharmaceuticals has announced that Surendera Tyagi is being brought in to join the company as Group Chief Scientific Officer …
Appointment

Boehringer’s Gilotrif approved in US for lung cancer with non-resistant EGFRs

January 16, 2018 Manufacturing and Production, Sales and Marketing Boehringer Ingelheim, Cancer, FDA, Giltrif, NSCLC, lung cancer

Boehringer Ingelheim is celebrating the FDA’s decision to expand the indication of its lung cancer drug Gilotrif (afatinib) to include …
News
mundipharma

Mundipharma signs Chinese licensing and distribution agreement with Grünenthal

January 16, 2018 Manufacturing and Production China, Grunenthal, Mundipharma, Tramal, pharma

US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on …
News
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026